FDA GOOD LAB PRACTICE PROPOSED REG REVISION ALLOWS PRODUCT CHARACTERIZATION AFTER INITIAL TOXICITY TESTS; CHANGES WOULD PROVIDE MORE FLEXIBILITY, FDA SAYS

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".